Clinical trials
1 active trial worldwide
Recruiting, about to start, or running now.
See every trial on ClinicalTrials.gov (opens in a new tab)Global Loiasis Public Health Report: Disease Burden, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook
| Country | Basic toilets (sanitation)of people | Basic drinking waterof people | Extreme povertyof people | Health spending from abroadof health spending |
|---|---|---|---|---|
| 16% 2024 | 36% 2024 | 85.3% 2020 | 37.0% 2023 | |
| 10% 2024 | 56% 2024 | 38.6% 2021 | 26.9% 2023 | |
| 32% 2024 | 90% 2024 | 39.0% 2016 | 8.5% 2023 | |
| 41% 2024 | 66% 2024 | 45.5% 2022 | 20.1% 2023 | |
| 48% 2024 | 82% 2024 | 41.8% 2022 | 11.3% 2023 | |
| 37% 2024 | 65% 2024 | 51.3% 2018 | 39.4% 2023 | |
| 24% 2024 | 63% 2024 | 54.4% 2023 | 44.1% 2023 |
Sources: World Bank, Our World in Data. A dash means no recent published figure.
Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.
| Topic | Loiasis |
|---|---|
| Place | Global |
| Basic toilets (sanitation) (latest) | 82% of people (2024)Source: World Bank Open Data, Basic toilets (sanitation) (% of people). Retrieved 22 Nov 2026. |
| Report sections | 16 (table of contents) |
| Active clinical trials | 1 worldwideSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Loiasis, or African eye worm, is a parasitic infection spread by deer flies. It complicates ivermectin campaigns because of the risk of severe reactions. This report covers loa loa infection and high-density infection.
The report sets out the prevalence, incidence and, where relevant, deaths from loiasis worldwide, and the overall burden, using Population Requiring Interventions, Mass Drug Administration Coverage, Reported Cases, Disability From NTDs and Elimination Status.
The burden is broken down by age (pre-school children, school-age children, adolescents, adults and older adults), gender and income, with a focus on rural poor communities, school-age children, women and girls, farmers and fishers, remote and nomadic communities and people living with NTD-Related disability.
Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.
Main risk factors include poverty, unsafe water and sanitation, contact with vectors, living near rivers and forests, poor housing and limited health services. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.
The report reviews how aware people are of loiasis and how far screening reaches them, through mapping and prevalence surveys, community case detection, rapid diagnostic tests and skin and eye examinations, by group and by area.
It compares the number of people diagnosed with the estimated number affected, to show the undiagnosed burden and how many people are lost between screening and treatment.
Treatment and prevention covered include test-and-not-treat strategies, loascope testing, alternative treatments and mapping, with how many people receive treatment and how many stay on it.
Long-term effects covered include disability and disfigurement, blindness, stigma and exclusion and lost schooling and income, along with other conditions that often occur alongside loiasis.
The report looks at primary health care, community drug distributors, laboratory and mapping teams and donated medicine supply chains, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.[1] The world scores 71 out of 100 on the WHO universal health coverage index (2023).[2] People pay 17.3% of all health spending out of their own pockets (2023).[3] ClinicalTrials.gov lists 1 study on Loiasis that is recruiting, active or about to start worldwide.[4]
[1] World Health Organization, universal health coverage. Checked 14 Nov 2026.
[2] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 22 Nov 2026.
[3] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 21 Nov 2026.
[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
It describes the costs of loiasis to health systems and households, including out-of-pocket spending and lost productivity, and how government, donors and NGOs fund the response.
Worldwide guidance and funding for loiasis include WHO NTD Road Map 2021–2030, Kigali Declaration on Neglected Tropical Diseases, Pharmaceutical Medicine Donation Programmes and Expanded Special Project for Elimination of NTDs (ESPEN). The report reviews national programmes, donor and NGO funding, and what is known about their impact.
Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.
The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.
It looks ahead at the likely future burden of loiasis, the healthcare it will need and the areas most vulnerable.
The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO Global Health Observatory NTD Data, ESPEN Portal, National NTD Programme Data and Global Burden of Disease (IHME). Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.
What doctors and scientists are doing in Loiasis Public Health Report right now, from free public sources.
1 active trial worldwide
Recruiting, about to start, or running now.
See every trial on ClinicalTrials.gov (opens in a new tab)82 % of people
Basic toilets (sanitation), World, 2024 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 22 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Medical Devices · Global
Medical Devices · Global
Pharmaceuticals · Global
OTC & Nutraceuticals · Global
Pharmaceuticals · Global
Medical Devices · Global